SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Maria G. Tektonidou, Zhong Wang, Abhijit Dasgupta, Michael M. Ward, Burden of Serious Infections in Adults With Systemic Lupus Erythematosus: A National Population-Based Study, 1996–2011, Arthritis Care & Research, 2015, 67, 8
  2. 2
    Javier A. Cavallasca, Cecilia A. Costa, Maria del Rosario Maliandi, Liliana E. Contini, Elena Fernandez de Carrera, Jorge L. Musuruana, Infecciones graves en pacientes con enfermedades autoinmunes tratados con ciclofosfamida, Reumatología Clínica, 2015, 11, 4, 221

    CrossRef

  3. 3
    Candace H. Feldman, Linda T. Hiraki, Wolfgang C. Winkelmayer, Francisco M. Marty, Jessica M. Franklin, Seoyoung C. Kim, Karen H. Costenbader, Serious Infections Among Adult Medicaid Beneficiaries With Systemic Lupus Erythematosus and Lupus Nephritis, Arthritis & Rheumatology, 2015, 67, 6
  4. 4
    Javier A. Cavallasca, Cecilia A. Costa, Maria del Rosario Maliandi, Liliana E. Contini, Elena Fernandez de Carrera, Jorge L. Musuruana, Severe Infections in Patients With Autoimmune Diseases Treated With Cyclophosphamide, Reumatología Clínica (English Edition), 2015, 11, 4, 221

    CrossRef

  5. 5
    Susanna Esposito, Samantha Bosis, Margherita Semino, Donato Rigante, Infection and Autoimmunity, 2015,

    CrossRef

  6. 6
    E. Borella, M. Domeneghetti, L. Palma, A. Doria, Infection and Autoimmunity, 2015,

    CrossRef

  7. 7
    Kyungmin Lee, Asima Bajwa, Clovis A Freitas-Neto, Jamie Lynne Metzinger, Bailey A Wentworth, C Stephen Foster, A comprehensive review and update on the non-biologic treatment of adult noninfectious uveitis: part I, Expert Opinion on Pharmacotherapy, 2014, 15, 15, 2141

    CrossRef

  8. 8
    S. Esposito, S. Bosis, M. Semino, D. Rigante, Infections and systemic lupus erythematosus, European Journal of Clinical Microbiology & Infectious Diseases, 2014, 33, 9, 1467

    CrossRef

  9. 9
    Tiffany Caza, Zachary Oaks, Andras Perl, Interplay of Infections, Autoimmunity, and Immunosuppression in Systemic Lupus Erythematosus, International Reviews of Immunology, 2014, 33, 4, 330

    CrossRef

  10. 10
    M. Nagappa, M. Netravathi, A.B. Taly, S. Sinha, P.S. Bindu, A. Mahadevan, Long-term efficacy and limitations of cyclophosphamide in myasthenia gravis, Journal of Clinical Neuroscience, 2014, 21, 11, 1909

    CrossRef

  11. 11
    E. M. Miloslavsky, U. Specks, P. A. Merkel, P. Seo, R. Spiera, C. A. Langford, G. S. Hoffman, C. G. M. Kallenberg, E. W. St.Clair, N. K. Tchao, L. Viviano, L. Ding, D. Iklé, M. Villarreal, B. Jepson, P. Brunetta, N. B. Allen, F. C. Fervenza, D. Geetha, K. Keogh, E. Y. Kissin, P. A. Monach, T. Peikert, C. Stegeman, S. R. Ytterberg, J. H. Stone, Rituximab for the Treatment of Relapses in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis, Arthritis & Rheumatology, 2014, 66, 11
  12. 12
    A. Oglesby, A. J. Shaul, T. Pokora, C. Paramore, L. Cragin, G. Dennis, S. Narayanan, A. Weinstein, Adverse Event Burden, Resource Use, and Costs Associated with Immunosuppressant Medications for the Treatment of Systemic Lupus Erythematosus: A Systematic Literature Review, International Journal of Rheumatology, 2013, 2013, 1

    CrossRef

  13. 13
    Kamoltip Lertchaisataporn, Nuntana Kasitanon, Suparaporn Wangkaew, Saowanee Pantana, Waraporn Sukitawut, Worawit Louthrenoo, An Evaluation of the Association of Leukopenia and Severe Infection in Patients With Systemic Lupus Erythematosus, Journal of Clinical Rheumatology, 2013, 19, 3, 115

    CrossRef

  14. 14
    Carolina Muñoz-Grajales, Luis Fernando Pinto Peñaranda, Carlos Jaime Velásquez Franco, Javier Darío Márquez Hernández, Mauricio Restrepo Escobar, Complicaciones infecciosas en lupus eritematoso sistémico, Revista Colombiana de Reumatología, 2013, 20, 3, 141

    CrossRef

  15. 15
    Manuel F Ugarte-Gil, Graciela S Alarcón, Is there an effective treatment for late-onset systemic lupus erythematosus?, Aging Health, 2013, 9, 4, 437

    CrossRef

  16. 16
    Savino Sciascia, Maria Jose Cuadrado, Mohammed Yousuf Karim, Management of infection in systemic lupus erythematosus, Best Practice & Research Clinical Rheumatology, 2013, 27, 3, 377

    CrossRef

  17. 17
    Chia-Tse Weng, Ming-Fei Liu, Meng-Yu Weng, Nan-Yao Lee, Ming-Chang Wang, Wei-Chieh Lin, Chih-Ying Ou, Wu-Wei Lai, Shiang-Chin Hsu, Sheau-Chiou Chao, Ta-Jung Chung, Chung-Ta Lee, Chi-Chang Shieh, Jiu-Yao Wang, Chrong-Reen Wang, Pneumocystis jirovecii Pneumonia in Systemic Lupus Erythematosus From Southern Taiwan, Journal of Clinical Rheumatology, 2013, 19, 5, 252

    CrossRef

  18. You have free access to this content18
    M. Kristen Demoruelle, Anthony Kahr, Kimi Verilhac, Kevin Deane, Aryeh Fischer, Sterling West, Recent-onset systemic lupus erythematosus complicated by acute respiratory failure, Arthritis Care & Research, 2013, 65, 2
  19. 19
    Tobias Brummaier, Erich Pohanka, Andrea Studnicka-Benke, Herwig Pieringer, Using cyclophosphamide in inflammatory rheumatic diseases, European Journal of Internal Medicine, 2013, 24, 7, 590

    CrossRef

  20. 20
    Erin M. Wilfong, Philip Seo, Vasculitis in the intensive care unit, Best Practice & Research Clinical Rheumatology, 2013, 27, 1, 95

    CrossRef

  21. 21
    Jacob M. Van Laar, Kelley's Textbook of Rheumatology, 2013,

    CrossRef

  22. 22
    Joseph Mosak, Richard Furie, Comparative Safety of Therapies in Systemic Lupus Erythematosus, Rheumatic Disease Clinics of North America, 2012, 38, 4, 795

    CrossRef

  23. 23
    Senthil K. Sivalingam, Pragathi Saligram, Sivakumar Natanasabapathy, Armando S. Paez, Covert Cryptococcal Meningitis in a Patient With Systemic Lupus Erythematous, The Journal of Emergency Medicine, 2012, 42, 5, e101

    CrossRef

  24. 24
    Yoshinori Matsumoto, Ken-ei Sada, Fumio Otsuka, Mariko Takano, Noriko Toyota, Koichi Sugiyama, Hiroshi Wakabayashi, Tomoko Kawabata, Hirofumi Makino, Evaluation of weekly-reduction regimen of glucocorticoids in combination with cyclophosphamide for anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis in Japanese patients, Rheumatology International, 2012, 32, 10, 2999

    CrossRef

  25. 25
    G. H. Stummvoll, S. Schmaldienst, J. S. Smolen, K. Derfler, P. Biesenbach, Lupus nephritis: prolonged immunoadsorption (IAS) reduces proteinuria and stabilizes global disease activity, Nephrology Dialysis Transplantation, 2012, 27, 2, 618

    CrossRef

  26. 26
    Ayman El Garf, Bassel El Zorkany, Rasha Gheith, Hala Sheba, Geilan Abdel Moneim, Kamal El Garf, Prevalence and clinical presentations of hepatitis C virus among patients admitted to the rheumatology ward, Rheumatology International, 2012, 32, 9, 2691

    CrossRef

  27. 27
    Stella Ntali, George Bertsias, Dimitrios T. Boumpas, Cyclophosphamide and Lupus Nephritis: When, How, For How Long?, Clinical Reviews in Allergy & Immunology, 2011, 40, 3, 181

    CrossRef

  28. 28
    Eva D. Papadimitraki, George Bertsias, George Chamilos, Dimitrios T. Boumpas, Systemic Lupus Erythematosus, 2011,

    CrossRef

  29. 29
    F. M. Ribeiro, M. Szyper-Kravitz, E. M. Klumb, G. Lannes, F. R. E. Ribeiro, E. M. M. Albuquerque, Y. Shoenfeld, Can Lupus Flares be Associated with Tuberculosis Infection?, Clinical Reviews in Allergy & Immunology, 2010, 38, 2-3, 163

    CrossRef

  30. 30
    A. Schuller, S. Hirschi, R. Kessler, Détresse respiratoire aiguë au cours d’un lupus, Revue des Maladies Respiratoires Actualités, 2010, 2, 2, 77

    CrossRef

  31. 31
    Eduardo F. Borba, Ana C. M. Ribeiro, Patricia Martin, Luciana P. Costa, Lissiane K. N. Guedes, Eloísa Bonfá, Incidence, Risk Factors, and Outcome of Herpes Zoster in Systemic Lupus Erythematosus, JCR: Journal of Clinical Rheumatology, 2010, 16, 3, 119

    CrossRef

  32. 32
    Koji Kinoshita, Kazuya Kishimoto, Hideki Shimazu, Yuji Nozaki, Masafumi Sugiyama, Shinya Ikoma, Masanori Funauchi, Successful Treatment With Retinoids in Patients With Lupus Nephritis, American Journal of Kidney Diseases, 2010, 55, 2, 344

    CrossRef

  33. 33
    Rocío González León, Rocío Garrido Rasco, Eduardo Chinchilla Palomares, Francisco José García Hernández, M. Jesús Castillo Palma, Julio Sánchez Román, Tuberculosis en una cohorte de pacientes con lupus eritematoso sistémico, Reumatología Clínica, 2010, 6, 5, 256

    CrossRef

  34. 34
    Rocío González León, Rocío Garrido Rasco, Eduardo Chinchilla Palomares, Francisco José García Hernández, M. Jesús Castillo Palma, Julio Sánchez Román, Tuberculosis in a cohort of patients with systemic lupus erythematosus, Reumatología Clínica (English Edition), 2010, 6, 5, 256

    CrossRef

  35. 35
    Meyler's Side Effects of Drugs in Cancer and Immunology, 2010,

    CrossRef

  36. 36
    Kamolwish Laoprasopwattana, Pornsak Dissaneewate, Prayong Vachvanichsanong, Fatal infection in children with lupus nephritis treated with intravenous cyclophosphamide, Pediatric Nephrology, 2009, 24, 7, 1337

    CrossRef

  37. 37
    Mona Ben m’rad, Dalenda Gherissi, Luc Mouthon, Dominique Salmon-Céron, Risque de tuberculose au cours des maladies systémiques, La Presse Médicale, 2009, 38, 2, 274

    CrossRef

  38. 38
    David Lebeaux, Fanny Lanternier, Agnès Lefort, Marc Lecuit, Olivier Lortholary, Risque infectieux fongique au cours des maladies systémiques, La Presse Médicale, 2009, 38, 2, 260

    CrossRef

  39. 39
    Arnaud Millet, Olivier Decaux, Antoinette Perlat, Bernard Grosbois, Patrick Jego, Systemic lupus erythematosus and vaccination, European Journal of Internal Medicine, 2009, 20, 3, 236

    CrossRef

  40. 40
    Thomas Hanslik, Paula Niedziolka, Solen Kernéis, Odile Launay, Vaccinations chez les patients ayant une maladie systémique, La Presse Médicale, 2009, 38, 2, 235

    CrossRef

  41. 41
    Laurence J. Egan, Pharmacology and Therapeutics, 2009,

    CrossRef

  42. 42
    M. Jallouli, M. Frigui, S. Marzouk, I. Mâaloul, N. Kaddour, Z. Bahloul, Complications infectieuses au cours du lupus érythémateux systémique : étude de 146 patients, La Revue de Médecine Interne, 2008, 29, 8, 626

    CrossRef

  43. 43
    Antonio Ramos, Infecciones en el paciente inmunodeficiente. ¿Qué papel tienen los fármacos?, Reumatología Clínica, 2008, 4, 1

    CrossRef

  44. 44
    Debasis Biswas, Amrita Mathias, Rajeshwar Dayal, Amita Aggarwal, Ramnath Misra, Sita Naik, Presence of antibodies to SSB/La is associated with decreased phagocytic efficiency of neutrophils in patients with systemic lupus erythematosus, Clinical Rheumatology, 2008, 27, 6, 717

    CrossRef

  45. 45
    VR Joshi, P Kharbanda, A Tembe, Prevention of infections in patients with rheumatic diseases, Indian Journal of Rheumatology, 2008, 3, 2, 58

    CrossRef

  46. 46
    Deepak Gupta, Anita Zachariah, Heidi Roppelt, Aarat M. Patel, Barry L. Gruber, Prophylactic Antibiotic Usage for Pneumocystis jirovecii Pneumonia in Patients With Systemic Lupus Erythematosus on Cyclophosphamide, JCR: Journal of Clinical Rheumatology, 2008, 14, 5, 267

    CrossRef

  47. 47
    Chih-Lung Hou, Yi-Chan Tsai, Li-Chen Chen, Jing-Long Huang, Tuberculosis infection in patients with systemic lupus erythematosus: pulmonary and extra-pulmonary infection compared, Clinical Rheumatology, 2008, 27, 5, 557

    CrossRef

  48. 48
    Hiromasa ARAI, Yasushi RINO, Keita FUJII, Nobuyasu SUGANUMA, Norio YUKAWA, Nobuyuki WADA, AN OPERATED CASE OF PYOTHORAX WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE), Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association), 2007, 68, 3, 557

    CrossRef

  49. 49
    Cheng-De Yang, Xiao-Dong Wang, Shuang Ye, Yue-Ying Gu, Chun-De Bao, Yuan Wang, Shun-Le Chen, Clinical features, prognostic and risk factors of central nervous system infections in patients with systemic lupus erythematosus, Clinical Rheumatology, 2007, 26, 6, 895

    CrossRef

  50. 50
    Carla Zoja, Federica Casiraghi, Sara Conti, Daniela Corna, Daniela Rottoli, Regiane A. Cavinato, Giuseppe Remuzzi, Ariela Benigni, Cyclin-dependent kinase inhibition limits glomerulonephritis and extends lifespan of mice with systemic lupus, Arthritis & Rheumatism, 2007, 56, 5
  51. 51
    M. Khalifa, N. Kaabia, F. Bahri, E. Ben Jazia, E. Bouajina, A. Omezzine Letaief, Infection in systemic lupus erythematosus, Médecine et Maladies Infectieuses, 2007, 37, 12, 792

    CrossRef

  52. 52
    C Zoja, D Corna, D Rottoli, C Zanchi, M Abbate, G Remuzzi, Imatinib ameliorates renal disease and survival in murine lupus autoimmune disease, Kidney International, 2006, 70, 1, 97

    CrossRef

  53. 53
    Graciela S. Alarcón, Infections in Systemic Connective Tissue Diseases: Systemic Lupus Erythematosus, Scleroderma, and Polymyositis/Dermatomyositis, Infectious Disease Clinics of North America, 2006, 20, 4, 849

    CrossRef

  54. 54
    C.-H. Chen, J.-D. Lian, C.-H. Cheng, M.-J. Wu, W.-C. Lee, K.-H. Shu, Mycobacterium tuberculosis infection following renal transplantation in Taiwan, Transplant Infectious Disease, 2006, 8, 3
  55. 55
    Hélène Maillard, David Launay, Eric Hachulla, Jenny Goudemand, Marc Lambert, Sandrine Morell-Dubois, Viviane Queyrel, Pierre-Yves Hatron, Rituximab in Postpartum-Related Acquired Hemophilia, The American Journal of Medicine, 2006, 119, 1, 86

    CrossRef

  56. 56
    Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions, 2006,

    CrossRef

  57. 57
    Gabor G Illei, Steven Z Pavletic, Blood stem cells as therapy for severe lupus, Expert Opinion on Biological Therapy, 2005, 5, 9, 1153

    CrossRef

  58. 58
    Annabelle A. Okada, Immunomodulatory Therapy for Ocular Inflammatory Disease: A Basic Manual and Review of the Literature, Ocular Immunology and Inflammation, 2005, 13, 5, 335

    CrossRef

  59. 59
    Sauwalak Opastirakul, Wattana Chartapisak, Infection in children with lupus nephritis receiving pulse and oral cyclophosphamide therapy, Pediatric Nephrology, 2005, 20, 12, 1750

    CrossRef

  60. 60
    Steven Z. Pavletic, Gabor G. Illei, The role of immune ablation and stem cell transplantation in severe SLE, Best Practice & Research Clinical Rheumatology, 2005, 19, 5, 839

    CrossRef

  61. 61
    Dana Kazlow Stern, Jackie M. Tripp, Vincent C. Ho, Mark Lebwohl, The Use of Systemic Immune Moderators in Dermatology: An Update, Dermatologic Clinics, 2005, 23, 2, 259

    CrossRef

  62. 62
    Katsuhiko TAKABAYASHI, Hideki HANAOKA, Opportunistic Infections, Japanese Journal of Clinical Immunology, 2004, 27, 3, 156

    CrossRef

  63. 63
    S. Vasoo, G.R.V. Hughes, Perspectives on the changing face of lupus mortality, Autoimmunity Reviews, 2004, 3, 6, 415

    CrossRef

  64. 64
    John C. Davis, John H. Klippel, Systemic Lupus Erythematosus, 2004,

    CrossRef

  65. 65
    C. Vadillo Font, C. Hernández-García, E. Pato, I.C. Morado, M. Salido, E. Júdez, P. Macarrón, B. Fernández-Gutiérrez, L. Abásolo, J.A. Jover, Incidencia y características de la tuberculosis en pacientes con enfermedades reumáticas autoinmunes, Revista Clínica Española, 2003, 203, 4, 178

    CrossRef

  66. 66
    Marcela Juárez, Richard Misischia, Graciela S Alarcón, Infections in systemic connective tissue diseases: systemic lupus erythematosus, scleroderma, and polymyositis/dermatomyositis, Rheumatic Disease Clinics of North America, 2003, 29, 1, 163

    CrossRef

  67. 67
    Kam Hon Yoon, Kok Yong Fong, Paul Ananth Tambyah, Fatal Cytomegalovirus Infection in Two Patients With Systemic Lupus Erythematosus Undergoing Intensive Immunosuppressive Therapy, JCR: Journal of Clinical Rheumatology, 2002, 8, 4, 217

    CrossRef

  68. 68
    John M. Esdaile, How to manage patients with lupus nephritis, Best Practice & Research Clinical Rheumatology, 2002, 16, 2, 195

    CrossRef

  69. 69
    Stephen B Greenberg, Infections in the immunocompromised rheumatologic patient, Critical Care Clinics, 2002, 18, 4, 931

    CrossRef

  70. 70
    M Koselj-Kajtna, M Koselj, T Rott, A Kandus, A Bren, Infectious complications of immunosuppressive treatment for anti-neutrophil cytoplasm antibody-related vasculitis, Transplantation Proceedings, 2002, 34, 7, 3001

    CrossRef

  71. 71
    Bernhard Hellmich, Elena Csernok, Masja de Haas, Albert E.G.K.R von dem Borne, Helmut Schatz, Wolfgang L Gross, Armin Schnabel, Low Fcγ receptor III and high granulocyte colony-stimulating factor serum levels correlate with the risk of infection in neutropenia due to Felty’s syndrome or systemic lupus erythematosus, The American Journal of Medicine, 2002, 113, 2, 134

    CrossRef

  72. 72
    Jacqueline Trager, Michael M. Ward, Mortality and causes of death in systemic lupus erythematosus, Current Opinion in Rheumatology, 2001, 13, 5, 345

    CrossRef

  73. 73
    Lindy P. Fox, Amit G. Pandya, PULSE INTRAVENOUS CYCLOPHOSPHAMIDE THERAPY FOR DERMATOLOGIC DISORDERS, Dermatologic Clinics, 2000, 18, 3, 459

    CrossRef

  74. 74
    Robert A. Ortmann, John H. Klippel, UPDATE ON CYCLOPHOSPHAMIDE FOR SYSTEMIC LUPUS ERYTHEMATOSUS, Rheumatic Disease Clinics of North America, 2000, 26, 2, 363

    CrossRef

  75. 75
    JONSSON, SVENSSON, CARLSTEN, Beneficial effect of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil on survival and severity of glomerulonephritis in systemic lupus erythematosus (SLE)-prone MRLlpr/lpr mice, Clinical & Experimental Immunology, 1999, 116, 3
  76. 76
    P. Niaudet, Traitement de la néphropathie du lupus érythémateux disséminé chez l'enfant, Archives de Pédiatrie, 1999, 6, 12, 1312

    CrossRef

  77. 77
    John H. Klippel, 8 Indications for, and use of, cytotoxic agents in SLE, Baillière's Clinical Rheumatology, 1998, 12, 3, 511

    CrossRef

  78. 78
    Jan P. Dutz, Vincent C. Ho, IMMUNOSUPPRESSIVE AGENTS IN DERMATOLOGY, Dermatologic Clinics, 1998, 16, 2, 235

    CrossRef

  79. 79
    Martin Aringer, Josef S. Smolen, Winfried B. Graninger, Severe infections in plasmapheresis-treated systemic lupus erythematosus, Arthritis & Rheumatism, 1998, 41, 3
  80. 80
    Michael D. Hill, Jacob Karsh, Invasive soft tissue infections with Streptococcls Pneumoniae in patients with systemic lupus erythematosus. Case report and review of the literatur, Arthritis & Rheumatism, 1997, 40, 9
  81. 81
    Graciela S. Alarcon, Relative risk and attributable risk needed to interpret “factors predictive of infection in cyclophosphamide-treated Lupus patients”: Comment on the article by Pryor et al, Arthritis & Rheumatism, 1997, 40, 6
  82. 82
    Graciela S. Alarcón, Relative risk and attributable risk needed to interpret “factors predictive of infection in cyclophosphamidetreated lupus patients”: Comment on the article by Pryor et al, Arthritis & Rheumatism, 1997, 40, 6
  83. 83
    Thierry Vial, Jacques Descotes, 1997,

    CrossRef